Real questions from health communities, answered with cited research from PubMed and Vellito's article corpus. Plain language, no medical advice. How this works.
Two main types of non-invasive brain stimulation (NIBS) are commonly used to treat aphasia: transcranial direct current stimulation (tDCS) and repetitive transcranial magnetic…
No single speech therapy is best for all people with aphasia; research shows several approaches can help, and the best choice depends on the individual.
Yes, antipsychotics are standard for schizophrenia; metformin can prevent weight gain from antipsychotics; antithrombotic agents show very low-certainty evidence for reducing…
A randomized trial indicates that high-frequency twirling acupuncture may improve language functions and quality of life for patients with post-stroke aphasia.
Yes, machine learning can help predict aphasia recovery after stroke, with models achieving around 80% accuracy using factors like aphasia severity, cognitive performance, and…
Yes, combining tDCS with therapy significantly improves verb naming in chronic post-stroke aphasia, with benefits lasting at least one month.
Yes, severe mental illness is linked to slightly less weight loss after bariatric surgery, likely due to medication effects and metabolic factors.
Yes, people with severe mental illness may experience slightly less weight loss after metabolic surgery, based on a meta-analysis showing a small but significant difference.
Yes, multiple phytochemicals from plants like Schisandra chinensis, oysters, and Artemisia stechmanniana show protective effects in animal models of alcoholic liver disease by…
The aMAP risk score is associated with increased mortality in patients with alcohol-related liver disease.
Yes, CAR-T cell therapy is highly effective for hematologic malignancies, with success in blood cancers like ALL, but faces challenges in solid tumors.
Yes, a high neutrophil-to-lymphocyte ratio (NLR) is linked to a higher risk of developing brain metastasis in lung cancer patients, according to a meta-analysis and other studies.
Osimertinib is effective for EGFR-mutated NSCLC patients with active brain metastases, with real-world data showing median progression-free survival of 12.4 months and…
Lung cancer brain metastasis is driven by tumor cells co-opting brain developmental pathways, secreting exosomal CEMIP and LCN2, and recruiting astrocytes and macrophages to…
Yes, stereotactic radiotherapy is an effective treatment for brain metastases, offering high local control rates and preserving cognitive function.
Endobronchial access has the lowest inaccurate placement rate and low complication risk, making it a strong choice for fiducial marker insertion before lung cancer radiation.
Brain metastases are common in lung cancer, especially small cell (15% at diagnosis) and non-small cell types, with elevated neutrophil-to-lymphocyte ratio as a risk factor…
Yes, a high neutrophil-to-lymphocyte ratio (NLR) is an independent risk factor for brain metastasis in lung cancer, according to a meta-analysis of 14 studies.
Yes, trastuzumab deruxtecan improves progression-free survival compared to chemotherapy in HR-positive, HER2-low breast cancer, but overall survival data are not yet mature.
Yes, early evidence suggests dose intensification to visible tumors may improve outcomes for intermediate- or high-risk prostate cancer, but ongoing trials will clarify safety…
Datopotamab deruxtecan did not improve overall survival compared to chemotherapy in metastatic HR-positive breast cancer, despite improving progression-free survival.
Yes, enzalutamide plus ADT significantly improves survival in metastatic hormone-sensitive prostate cancer, with a 34% reduction in risk of death and a 5-year survival rate of…
Yes, research on macrophage polarization in prostate cancer has grown significantly since 2015, with studies exploring its role in tumor progression and therapy resistance.
Quality of life for colorectal cancer survivors is influenced by physical symptoms, psychological distress, social support, self-efficacy, and demographic factors like age and…
We pull real patient questions from public Reddit health communities (r/AskDocs, r/diabetes, r/menopause, etc.). Each question is rewritten into a generic medical question (no personal details), then answered by an AI using only cited sources from Vellito's article database and PubMed. A second AI independently scores each answer for accuracy and citation fidelity before publication. Answers below the safety threshold or touching emergency, dosing, or pediatric topics are queued for human review and never auto-published.
This is not medical advice. Always speak with your own doctor before making decisions about your health.